Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
EUDA Health Holdings ( (EUDA) ) has provided an update.
On January 13, 2026, EUDA Health Holdings Limited announced that its wholly owned subsidiary EUDA Health Pte. Ltd. entered into a convertible loan agreement with Shenzhen Inno Immune Co., Ltd., a Chinese developer of autologous cellular therapeutics and customized medicines. EUDA plans to invest up to RMB 6 million in two tranches, structured as a 6% per annum convertible loan note that can be converted into an equity stake in Shenzhen Inno or redeemed with interest, subject to due diligence, regulatory approvals and definitive documentation. The funds will be used by Shenzhen Inno to upgrade its cGMP facility in Shenzhen into a state-of-the-art production and innovation center for stem cell treatments, which is intended to become a core technology and operating hub for EUDA’s China strategy, anchoring its regenerative medicine capabilities and providing a scalable platform for expansion into additional cities and markets. The deal deepens EUDA’s move toward a vertically integrated stem cell and regenerative medicine platform, leveraging Shenzhen Inno’s established cell technology and therapy operations and institutional backing, and is designed to enhance EUDA’s technology, infrastructure and operational depth in the region’s high-growth longevity and advanced therapeutics sectors.
The most recent analyst rating on (EUDA) stock is a Buy with a $6.00 price target. To see the full list of analyst forecasts on EUDA Health Holdings stock, see the EUDA Stock Forecast page.
More about EUDA Health Holdings
EUDA Health Holdings Limited is a Singapore-based, non-invasive and preventive healthcare provider operating across Singapore, Malaysia and China, with a strategic focus on the fast-growing longevity sector in Asia. Aiming to serve the evolving healthcare needs of over 1.8 billion people in a rapidly aging region, the company offers innovative, accessible and science-backed health solutions to shift care from reactive treatment to proactive, longevity-focused services, and also operates a Singapore-based property management business.
Average Trading Volume: 349,341
Technical Sentiment Signal: Sell
Current Market Cap: $87.34M
See more insights into EUDA stock on TipRanks’ Stock Analysis page.